Bacteremia Due To Leclercia Adecarboxylata in an Immunocompromised Patient From A Tertiary Care Centre in North India: A Case Report
Leclerciaadecarboxylata (LAD), despite its low virulence and ubiquity it has been recognized as an emerging human pathogen in both immunocompromised and immunocompetent patients. Correct identification of LAD in clinical specimens is necessary for epidemiological data, diagnosis, treatment, and resistance profile.We report a case that illustrates the importance of considering LAD as a possible cause of infections in immunocompromised patients
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-08-31
- DOI
- https://doi.org/10.5281/zenodo.17033710
- Primary Topic
- Geochemistry and Geologic Mapping
- Type
- article
- Field-Weighted Citation Impact
- 0.00